Paula Pohlmann

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Catherine Lai

UNITED STATES

View details

Stephen Liu

Associate Professor

Georgetown University School of Medicine

UNITED STATES

View details

Sarina Piha-Paul

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Yuan Yuan

Scripps Research Institute

UNITED STATES

View details

Mohamed Gouda

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Claudine Isaacs

Professor of Medicine

Georgetown University

UNITED STATES

View details

Timothy Yap

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paula Pohlmann

Research Interests

Explore related searches

Contact this professor

Articles (10)

Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer

CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.

A First-in-Human Study of cinrebafusp alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies

Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial

A phase I trial of palbociclib and bosutinib with fulvestrant in patients with metastatic hormone receptor positive and HER2 negative (HR+ HER2-) breast cancer refractory to an aromatase inhibitor and a CDK4/6 inhibitor

HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane

Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions

Circulating Tumor Cells: Technologies and Their Clinical Potential in Cancer Metastasis

An evaluation of palbociclib as a breast cancer treatment option: a current update

Rebound lymphocytosis in a patient with chronic lymphocytic leukemia after cessation of a CDK 4/6 inhibitor for concomitant breast cancer

Collaborators (7)

Catherine Lai

Stephen Liu

Sarina Piha-Paul

Yuan Yuan

Mohamed Gouda

Claudine Isaacs

Timothy Yap

Make your next move.